Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)

Giustini N, Bazhenova L

Lung Cancer: Targets and Therapy 2021, 12:21-34

Published Date: 25 March 2021